Drugs / Freeze-Dried Black Raspberry Powder
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03140280 | Jun 2017 → Jun 2019 | myelodysplastic syndrome | Ehab L Atallah | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Freeze-Dried Black Raspberry Powder | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03140280 ↗ |
| Route | Oral | “25 gm (2x/day) of freeze-dried black raspberry powder taken orally in 8 ounces of water for 12 weeks.” NCT03140280 ↗ |